ArticleBiochemistry and biophysics reports2025
Increased production of humoral factor and PD-L1 expression induced by cytokine stimulation play a key role in the immunosuppressive effects of stem cells derived from human exfoliated deciduous teeth.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recently, the efficacy of mesenchymal stem cells (MSC) targeting transplant immunosuppression has been reported, and their application to islet transplantation is also expected. However, since the stability of functional manifestation of MSC remains unclear, we have investigated the stability and efficacy of cytokine-stimulated stem cells from human exfoliated deciduous teeth (SHED) in the human immune system in order to establish a safety clinical application. Methods: SHED were stimulated with TNF-α, IL-1β, and IFN-γ, which were elevated post-transplant in the liver. Flow cytometry was used to analyze surface antigen expression. Human peripheral blood mononuclear cells (PBMC) were co-cultured with stimulated SHED directly or indirectly to assess PBMC proliferation. Cytotoxicity assay evaluated PBMC-induced damage to induced pluripotent stem (iPS) cell-derived human pancreatic beta-like cells. ELISA measured immunomodulatory factor secretion. Results: Programmed death-ligand 1 (PD-L1) expression was assessed, and PBMC were co-cultured with stimulated SHED in the presence of anti-PD-L1 antibody. SHED were also reaggregated with dissociated human pancreatic islets to generate islet-like organoids, and insulin secretion was measured. Stimulated SHED showed minimal change in cell surface markers but significantly inhibited PBMC proliferation and cytotoxicity, Stimulated SHED produced elevated levels of immunosuppressive factors and expressed PD-L1. The immunosuppressive effect was partially inhibited by inhibiting cell contact between SHED and PBMC or blocking the PD-1/PD-L1 pathway. Furthermore, insulin secretion was enhanced in reaggregated human pancreatic islets with SHED. Conclusions: We demonstrated that the use of SHED in its activated state effectively suppresses immune response and maintains graft function at the time of islet transplantation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.